New advisory board member
Panion Animal Health AB develops a gene therapy product for treatment of epilepsy in dogs, for which the clinical phase has started.
Panion’s highly competent advisory board has now been expanded with the fourth member, Dr. Dominic J. Marino, DVM, DACVS, DACCT, CCRP, who is the lead investigator of the ongoing clinical study in dogs.
Dr. Dominic J. Marino is an experienced veterinary neurologist and neurosurgeon He is the Chief of Staff of Long Island Veterinary Specialists, the Director of the Canine Chiari Institute, and a founding board member of the New York Veterinary Foundation. Dr. Marino pursued his life-long animal passion by attending Auburn University in Alabama where he attained a B.S. in biology and a DVM degree. Dr. Marino is board certified by the American College of Veterinary Surgeons and the American College of Clinical Thermology and is the former head of Orthopedic/Neurosurgery service at the Animal Medical Center. Fulfilling his desire to make cutting-edge veterinary medicine available to the pets of Long Island, he joined with Drs. Kaplan, Sapienza, and Panich to start Island Veterinary Referral which later evolved into Long Island Veterinary Specialists.
Dr. Marino has published many scientific articles, and authored chapters in both human and veterinary medical textbooks. He lectures extensively on many surgical topics including soft tissue, orthopedic and neurosurgery at both human and veterinary surgical conferences nationally and internationally. Dr. Marino has participated in collaborative research projects with several institutions including Stonybrook Medical School and Brookhaven National Laboratory on Long Island.
Dr. Marino served as the surgical consultant to Nassau University Medical Center, East Meadow, NY, chairman of the Eastern Veterinary Orthopedic Society, and on the National Advisory Board of North Shore Animal League of America. He is currently an executive board member of the New York Veterinary Foundation, The Police Surgeons Benevolent Association and the medical advisory board of the CSF foundation.
“We are very pleased that Dr. Marino makes his expertise available for Panion’s epilepsy project in dogs. As a true expert in the field, his advice and guidance will be of tremendous benefit to us” says Anja Holm, CEO of Panion.
Anja E. H. Holm, CEO
+ 45-22 94 66 00
Bolaget ska utveckla och kommersialisera genterapi för behandling av epilepsiliknande tillstånd hos hundar och andra djur, samt utveckla och kommersialisera andra veterinärmedicinska produkter och nya behandlingsformer som kan ge sjuka djur bättre livskvalitet.
Panion will develop and commercialize a gene therapy treatment for dogs with drug refractory epilepsy, and other new animal health products and treatments that improve the quality of life for animals suffering from chronic diseases.